Continued disparity among IBD diagnoses

Continued disparity among IBD diagnoses
Source:
Barnes E, et al. Abstract 251. Presented at: Digestive Disease Week; May 21-23, 2021 (virtual meeting).
Disclosures:
Barnes reports consulting for AbbVie, Gilead, Pfizer, Takeda ad Target RWE. Please see the study for all other authors’ relevant financial disclosures.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Subscribe
ADDED TO EMAIL ALERTS
You've successfully added to your alerts. You will receive an email when new content is published.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Related Keywords

United States ,American ,Edward Barnes ,Kate Burba ,Pfizer ,University Of North Carolina At Chapel Hill ,Digestive Disease Week ,Digestive Disease ,North Carolina ,Chapel Hill ,African American ,ஒன்றுபட்டது மாநிலங்களில் ,அமெரிக்கன் ,எட்வர்ட் களஞ்சியங்கள் ,கேட் பர்பா ,ஃபைசர் ,பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா இல் தேவாலயம் மலை ,செரிமான நோய் வாரம் ,செரிமான நோய் ,வடக்கு கரோலினா ,தேவாலயம் மலை ,